ProCE Banner Activity

DolPHIN-2: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Initiated in Late Pregnancy

Slideset Download
Conference Coverage
In pregnant women with HIV infection who initiated third trimester ART, HIV-1 RNA < 50 copies/mL at delivery achieved in 74% with DTG-based therapy vs 43% with EFV-based therapy.

Released: March 08, 2019

Expiration: March 06, 2020

Share

Provided by

Jointly provided by the Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ProCE Banner

Supporters

This program is supported by independent educational grants from

Gilead

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare